Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FZ0EY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,452
Award facts
- Contract value 100% obligated
- $4,451.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,451.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive delivery order was issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Entresto is a cardiac medication combining sacubitril and valsartan, commonly prescribed for heart failure management in military and veteran populations. The delivery order represents a typical transaction within AmerisourceBergen's expansive federal medical supply portfolio, which includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical devices. As a child delivery order under the broader DLA SPE2DX IDC, this award demonstrates AmerisourceBergen's ongoing capability to fulfill federal pharmaceutical procurement requirements through open competitive processes and flexible contract vehicles supporting military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FZ0EY?
SPE2DB25FZ0EY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FZ0EY worth?
The government has obligated $4,452 on SPE2DB25FZ0EY.
Is contract SPE2DB25FZ0EY an order under another contract?
Yes. SPE2DB25FZ0EY is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0EY competed?
The extent of competition for SPE2DB25FZ0EY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award